Palvella Therapeutics (PVLA) Revenue (2016 - 2024)
Historic Revenue for Palvella Therapeutics (PVLA) over the last 11 years, with Q4 2024 value amounting to -$181000.0.
- Palvella Therapeutics' Revenue fell 11393.38% to -$181000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$128000.0, marking a year-over-year decrease of 10029.83%. This contributed to the annual value of -$430000.0 for FY2024, which is 10100.44% down from last year.
- As of Q4 2024, Palvella Therapeutics' Revenue stood at -$181000.0, which was down 11393.38% from $53000.0 recorded in Q1 2024.
- Over the past 5 years, Palvella Therapeutics' Revenue peaked at $20.1 million during Q2 2023, and registered a low of -$181000.0 during Q4 2024.
- Over the past 5 years, Palvella Therapeutics' median Revenue value was $4.7 million (recorded in 2021), while the average stood at $7.1 million.
- Its Revenue has fluctuated over the past 5 years, first soared by 44315.85% in 2023, then plummeted by 11393.38% in 2024.
- Quarter analysis of 5 years shows Palvella Therapeutics' Revenue stood at $1.9 million in 2020, then skyrocketed by 349.81% to $8.4 million in 2021, then plummeted by 30.76% to $5.8 million in 2022, then plummeted by 77.78% to $1.3 million in 2023, then tumbled by 113.93% to -$181000.0 in 2024.
- Its Revenue was -$181000.0 in Q4 2024, compared to $53000.0 in Q1 2024 and $1.3 million in Q4 2023.